"Designing Growth Strategies is in our DNA"

Leukemia Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Type of Leukemia (Chronic Myeloid Leukemia (CML), Chronic Lymphocytic Leukemia (CLL), Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML)), By Treatment Type (Chemotherapy, Targeted Therapy), By Route of Administration (Oral Mode and Injectable Mode), By Distribution Channels (Hospital Pharmacy, Retail Pharmacy), and Regional Forecast, 2020-2027

Region : Global | Format: PDF | Report ID: FBI104754

 

Table of Content:

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Pipeline Analysis, Key Players
    2. Prevalence of Leukemia, Key Countries, 2019
    3. Key Industry Developments (Mergers, Acquisition, etc.)
    4. Impact of Covid-19 on the Leukemia Therapeutics Market
  5. Global Leukemia Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type of Leukemia
      1. Chronic Myeloid Leukemia (CML)
      2. Chronic Lymphocytic Leukemia (CLL)
      3. Acute Lymphocytic Leukemia (ALL)
      4. Acute Myeloid Leukemia (AML)
      5. Others
    3. Market Analysis, Insights and Forecast – By Treatment Type
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
      4. Others
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Injectable Mode
      2. Oral Mode
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
    6. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Leukemia Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Type of Leukemia
      1. Chronic Myeloid Leukemia (CML)
      2. Chronic Lymphocytic Leukemia (CLL)
      3. Acute Lymphocytic Leukemia (ALL)
      4. Acute Myeloid Leukemia (AML)
      5. Others
    3. Market Analysis – By Treatment Type
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
      4. Others
    4. Market Analysis – By Route of Administration
      1. Injectable Mode
      2. Oral Mode
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
    6. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Leukemia Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Type of Leukemia
      1. Chronic Myeloid Leukemia (CML)
      2. Chronic Lymphocytic Leukemia (CLL)
      3. Acute Lymphocytic Leukemia (ALL)
      4. Acute Myeloid Leukemia (AML)
      5. Others
    3. Market Analysis – By Treatment Type
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
      4. Others
    4. Market Analysis – By Route of Administration
      1. Injectable Mode
      2. Oral Mode
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
    6. Market Analysis – By Country/Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Rest of Europe
  8. Asia Pacific Leukemia Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Type of Leukemia
      1. Chronic Myeloid Leukemia (CML)
      2. Chronic Lymphocytic Leukemia (CLL)
      3. Acute Lymphocytic Leukemia (ALL)
      4. Acute Myeloid Leukemia (AML)
      5. Others
    3. Market Analysis – By Treatment Type
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
      4. Others
    4. Market Analysis – By Route of Administration
      1. Injectable Mode
      2. Oral Mode
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
    6. Market Analysis – By Country/Sub-Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Rest of Asia Pacific
  9. Latin America Leukemia Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Type of Leukemia
      1. Chronic Myeloid Leukemia (CML)
      2. Chronic Lymphocytic Leukemia (CLL)
      3. Acute Lymphocytic Leukemia (ALL)
      4. Acute Myeloid Leukemia (AML)
      5. Others
    3. Market Analysis – By Treatment Type
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
      4. Others
    4. Market Analysis – By Route of Administration
      1. Injectable Mode
      2. Oral Mode
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
    6. Market Analysis – By Country/Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Leukemia Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Type of Leukemia
      1. Chronic Myeloid Leukemia (CML)
      2. Chronic Lymphocytic Leukemia (CLL)
      3. Acute Lymphocytic Leukemia (ALL)
      4. Acute Myeloid Leukemia (AML)
      5. Others
    3. Market Analysis – By Treatment Type
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
      4. Others
    4. Market Analysis – By Route of Administration
      1. Injectable Mode
      2. Oral Mode
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
    6. Market Analysis – By Country/Sub-Region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Pfizer Inc.
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Novartis
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Sanofi/ Genzyme Corporation
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Lupin Ltd.
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. Amgen Inc.
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. AbbVie
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Johnson & Johnson Services, Inc.
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Bristol-Myers Squibb
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. F. Hoffmann-La Roche
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      10. Takeda Pharmaceutical Co Ltd
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      11. Sanofi/ Genzyme Corporation
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)

List of Figures:

Figure 1:  Global Leukemia Therapeutics Market Revenue Breakdown (USD billion, %) by Region, 2016 & 2027

Figure 2:  Global Leukemia Therapeutics Market Value Share (%), by Type of Leukemia, 2016 & 2027

Figure 3:  Global Leukemia Therapeutics Market Value Share (%), by Treatment Type, 2016 & 2027

Figure 4:  Global Leukemia Therapeutics Market Value Share (%), by Route of Administration, 2016 & 2027

Figure 5:  Global Leukemia Therapeutics Market Value Share (%), by Distribution Channel, 2016 & 2027

Figure 6:  Global Leukemia Therapeutics Market Value (USD billion), by Region, 2016 & 2027

Figure 7:  North America Leukemia Therapeutics Market Value (USD billion), by Type of Leukemia, 2016 & 2027

Figure 8:  North America Leukemia Therapeutics Market Value Share (%), by Type of Leukemia, 2019

Figure 9:  North America Leukemia Therapeutics Market Value (USD billion), by Treatment Type, 2016 & 2027

Figure 10:  North America Leukemia Therapeutics Market Value Share (%), by Treatment Type, 2019

Figure 11:  North America Leukemia Therapeutics Market Value (USD billion), by Route of Administration, 2016 & 2027

Figure 12:  North America Leukemia Therapeutics Market Value Share (%), by Route of Administration, 2019

Figure 13:  North America Leukemia Therapeutics Market Value (USD billion), by Distribution Channel, 2016 & 2027

Figure 14:  North America Leukemia Therapeutics Market Value Share (%), by Distribution Channel, 2019

Figure 15:  North America Leukemia Therapeutics Market Value (USD billion), By Country, 2016 & 2027

Figure 16:  North America Leukemia Therapeutics Market Value Share (%), By Country, 2019

Figure 17:  Europe Leukemia Therapeutics Market Value (USD billion), by Type of Leukemia, 2016 & 2027

Figure 18:  Europe Leukemia Therapeutics Market Value Share (%), by Type of Leukemia, 2019

Figure 19:  Europe Leukemia Therapeutics Market Value (USD billion), by Treatment Type, 2016 & 2027

Figure 20:  Europe Leukemia Therapeutics Market Value Share (%), by Treatment Type, 2019

Figure 21:  Europe Leukemia Therapeutics Market Value (USD billion), by Route of Administration, 2016 & 2027

Figure 22:  Europe Leukemia Therapeutics Market Value Share (%), by Route of Administration, 2019

Figure 23:  Europe Leukemia Therapeutics Market Value (USD billion), by Distribution Channel, 2016 & 2027

Figure 24:  Europe Leukemia Therapeutics Market Value Share (%), by Distribution Channel, 2019

Figure 25:  Europe Leukemia Therapeutics Market Value (USD billion), By Country/ Sub-region, 2016 & 2027

Figure 26:  Europe Leukemia Therapeutics Market Value Share (%), By Country/ Sub-region, 2019

Figure 27:  Asia Pacific Leukemia Therapeutics Market Value (USD billion), by Type of Leukemia, 2016 & 2027

Figure 28:  Asia Pacific Leukemia Therapeutics Market Value Share (%), by Type of Leukemia, 2019

Figure 29:  Asia Pacific Leukemia Therapeutics Market Value (USD billion), by Treatment Type, 2016 & 2027

Figure 30:  Asia Pacific Leukemia Therapeutics Market Value Share (%), by Treatment Type, 2019

Figure 31:  Asia Pacific Leukemia Therapeutics Market Value (USD billion), by Route of Administration, 2016 & 2027

Figure 32:  Asia Pacific Leukemia Therapeutics Market Value Share (%), by Route of Administration, 2019

Figure 33:  Asia Pacific Leukemia Therapeutics Market Value (USD billion), by Distribution Channel, 2016 & 2027

Figure 34:  Asia Pacific Leukemia Therapeutics Market Value Share (%), by Distribution Channel, 2019

Figure 35:  Asia Pacific Leukemia Therapeutics Market Value (USD billion), By Country/ Sub-region, 2016 & 2027

Figure 36:  Asia Pacific Leukemia Therapeutics Market Value Share (%), By Country/ Sub-region, 2019

Figure 37:  Latin America Leukemia Therapeutics Market Value (USD billion), by Type of Leukemia, 2016 & 2027

Figure 38:  Latin America Leukemia Therapeutics Market Value Share (%), by Type of Leukemia, 2019

Figure 39:  Latin America Leukemia Therapeutics Market Value (USD billion), by Treatment Type, 2016 & 2027

Figure 40:  Latin America Leukemia Therapeutics Market Value Share (%), by Treatment Type, 2019

Figure 41:  Latin America Leukemia Therapeutics Market Value (USD billion), by Route of Administration, 2016 & 2027

Figure 42:  Latin America Leukemia Therapeutics Market Value Share (%), by Route of Administration, 2019

Figure 43:  Latin America Leukemia Therapeutics Market Value (USD billion), by Distribution Channel, 2016 & 2027

Figure 44:  Latin America Leukemia Therapeutics Market Value Share (%), by Distribution Channel, 2019

Figure 45:  Latin America Leukemia Therapeutics Market Value (USD billion), By Country/ Sub-region, 2016 & 2027

Figure 46:  Latin America Leukemia Therapeutics Market Value Share (%), By Country/ Sub-region, 2019

Figure 47:  Middle East & Africa Leukemia Therapeutics Market Value (USD billion), by Type of Leukemia, 2016 & 2027

Figure 48:  Middle East & Africa Leukemia Therapeutics Market Value Share (%), by Type of Leukemia, 2019

Figure 49:  Middle East & Africa Leukemia Therapeutics Market Value (USD billion), by Treatment Type, 2016 & 2027

Figure 50:  Middle East & Africa Leukemia Therapeutics Market Value Share (%), by Treatment Type, 2019

Figure 51:  Middle East & Africa Leukemia Therapeutics Market Value (USD billion), by Route of Administration, 2016 & 2027

Figure 52:  Middle East & Africa Leukemia Therapeutics Market Value Share (%), by Route of Administration, 2019

Figure 53:  Middle East & Africa Leukemia Therapeutics Market Value (USD billion), by Distribution Channel, 2016 & 2027

Figure 54:  Middle East & Africa Leukemia Therapeutics Market Value Share (%), by Distribution Channel, 2019

Figure 55:  Middle East & Africa Leukemia Therapeutics Market Value (USD billion), By Country/ Sub-region, 2016 & 2027

Figure 56:  Middle East & Africa Leukemia Therapeutics Market Value Share (%), By Country/ Sub-region, 2019

Figure 57:  Global Leukemia Therapeutics Market Share (%), By Company, 2019

List of Tables:

Table 1:  Global Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Type of Leukemia, 2016-2027

Table 2:  Global Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Treatment Type, 2016-2027

Table 3:  Global Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration, 2016-2027

Table 4:  Global Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2016-2027

Table 5:  Global Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Region, 2016-2027

Table 6:  North America Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Type of Leukemia, 2016-2027

Table 7:  North America Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Treatment Type, 2016-2027

Table 8:  North America Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration, 2016-2027

Table 9:  North America Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2016-2027

Table 10:  North America Leukemia Therapeutics Market Revenue (USD billion) Forecast, By Country, 2016-2027

Table 11:  Europe Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Type of Leukemia, 2016-2027

Table 12:  Europe Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Treatment Type, 2016-2027

Table 13:  Europe Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration, 2016-2027

Table 14:  Europe Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2016-2027

Table 15:  Europe Leukemia Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2016-2027

Table 16:  Asia Pacific Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Type of Leukemia, 2016-2027

Table 17:  Asia Pacific Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Treatment Type, 2016-2027

Table 18:  Asia Pacific Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration, 2016-2027

Table 19:  Asia Pacific Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2016-2027

Table 20:  Asia Pacific Leukemia Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2016-2027

Table 21:  Latin America Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Type of Leukemia, 2016-2027

Table 22:  Latin America Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Treatment Type, 2016-2027

Table 23:  Latin America Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration, 2016-2027

Table 24:  Latin America Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2016-2027

Table 25:  Latin America Leukemia Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2016-2027

Table 26:  Middle East & Africa Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Type of Leukemia, 2016-2027

Table 27:  Middle East & Africa Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Treatment Type, 2016-2027

Table 28:  Middle East & Africa Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration, 2016-2027

Table 29:  Middle East & Africa Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2016-2027

Table 30:  Middle East & Africa Leukemia Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2016-2027

 class=
  • Feb, 2021
  • 2019
  • 2016-2018
  • 140

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X